IL-13

Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...

New York, New York, September 17, 2026 Inductive Bio has launched Beacon-2, a new artificial intelligence system designed to...

San Diego, California, and Austin, Texas, September 17, 2026 Aethlon Medical, Inc. and North Immunology, Inc. have announced a...

Plainsboro, New Jersey, and Bagsværd, Denmark, September 17, 2026 Novo Nordisk has announced published Phase 3b results from the...

SAN DIEGO, Calif. — September 15, 2026 Connect Biopharma Holdings Limited announced positive preliminary topline results from the global...

NEW YORK and WALTHAM, Mass., August 4, 2026 Dianthus Therapeutics, Inc. announced the launch of DNTH312, an internally developed...

BRISBANE, Calif., August 4, 2026 Nurix Therapeutics, Inc. announced it has earned a $10 million development milestone payment after...

SAN FRANCISCO & BOSTON | January 6, 2026 — Apogee Therapeutics has reported positive interim results from a Phase...